Does the proteasome inhibitor bortezomib sensitize to DNA-damaging therapy in gastroenteropancreatic neuroendocrine neoplasms? - A preclinical assessment in vitro and in vivo.
蛋白酶体抑制剂硼替佐米能否增强胃肠胰神经内分泌肿瘤对DNA损伤疗法的敏感性？——体外和体内临床前评估
期刊:Neoplasia
影响因子:7.7
doi:10.1016/j.neo.2020.11.004
Briest Franziska, Koziolek Eva J, Albrecht Jakob, Schmidt Fränze, Bernsen Monique R, Haeck Joost, Kühl Anja A, Sedding Dagmar, Hartung Teresa, Exner Samantha, Welzel Martina, Fischer Christian, Grötzinger Carsten, Brenner Winfried, Baum Richard P, Grabowski Patricia
